In trading on Wednesday, shares of GameStop Corp (Symbol: GME) crossed above their 200 day moving average of $23.27, changing hands as high as $23.50 per share. GameStop Corp shares are currently trading up about 2.3% on the day. The chart below shows the one year performance
In trading on Wednesday, shares of GameStop Corp (Symbol: GME) crossed above their 200 day moving average of $23.27, changing hands as high as $23.50 per share. GameStop Corp shares are currently trading up about 2.3% on the day. The chart below shows the one year performance
The Trump administration has failed to provide a nominee to become permanent director of the CDC despite a Wednesday deadline. The delay means that National Institutes of Health chief Jay Bhattacharya will continue to also steer the CDC, though he will lose the title of acting director. The trouble finding CDC's new leader is due to growing political and operational pressures, according to The Was...
The Trump administration has failed to provide a nominee to become permanent director of the CDC despite a Wednesday deadline. The delay means that National Institutes of Health chief Jay Bhattacharya will continue to also steer the CDC, though he will lose the title of acting director. The trouble finding CDC's new leader is due to growing political and operational pressures, according to The Washington Post . The newspaper noted , citing officials, that about six people are under consideration, but the White House is taking its time to vet each candidate. Bloomberg recently reported that Joseph Marine, a cardiologist at Johns Hopkins Medicine, and Ernie Fletcher, a family physician and former governor of Kentucky, are among the contenders. During President Trump's second term, the CDC has been mostly led by acting directors. Susan Monarez was director for barely a month, from July 31 to August 27, 2025, before being fired, apparently for refusing to follow orders from HHS Secretary Robert F. Kennedy Jr. regarding changes to vaccine policies. She was replaced by acting director Jim O'Neill, who was deputy HHS secretary at the time. More on Pfizer, Moderna Pfizer: Undervalued High-Yield Giant With A Pipeline Built For The Next Decade Pfizer: Time To Buy The Turnaround Pfizer: I'm Still Expecting A Massive Rebound Pfizer, Valneva SE report phase 3 results for Lyme vaccine candidate Trump administration reportedly shortlisting CDC nominees
Postal carrier Marc Jacques delivers the mail in a neighborhood on March 19, 2026 in Miami, Florida. Joe Raedle | Getty Images The U.S. Postal Service on Wednesday said it is seeking to impose a temporary 8% fuel surcharge for package and express mail deliveries to deal with rising transportation costs, which include higher oil prices as a result of the Iran war . If approved by the Postal Regulat...
Postal carrier Marc Jacques delivers the mail in a neighborhood on March 19, 2026 in Miami, Florida. Joe Raedle | Getty Images The U.S. Postal Service on Wednesday said it is seeking to impose a temporary 8% fuel surcharge for package and express mail deliveries to deal with rising transportation costs, which include higher oil prices as a result of the Iran war . If approved by the Postal Regulatory Commission , the surcharge would take effect April 26 and remain in place until Jan. 17, 2027, the Postal Service said in a notice on its website. The 8% surcharge would apply to postage on Priority Mail Express, Priority Mail, USPS Ground Advantage, and Parcel Select products. First-class stamps and other mail services would not be affected. Oil prices have jumped more than 40% since Feb. 28, when the United States and Israel attacked Iran . Read more U.S.-Iran war news Trump tells CNBC 'we are very intent on making a deal' with Iran Oil tumbles after Trump postpones U.S. strikes against Iran energy infrastructure for five days European stocks stage rebound as Trump signals Iran war de-escalation Gold and silver pare losses as Trump postpones strikes More than 40 Middle East energy assets 'severely damaged,' IEA chief says Saudi Aramco boss pulls out of major international energy conference due to Iran conflict: Reuters Trump and Tehran issue dueling warnings on the Strait of Hormuz Iran threatens U.S. Treasury buyers as Trump's 48-hour ultimatum looms U.K. confirms Iran fired two missiles at British-American base in Indian Ocean U.S. allows 30-day sale of Iran oil at sea in bid to tame prices Trump: Don't want Iran war ceasefire, considering 'winding down' military Trump: U.S. could end Iran war but will continue so it can 'never rebuild' Netanyahu: Iran 'decimated' but revolution requires 'ground component' Trump invokes Pearl Harbor in front of Japanese PM to defend Iran attack Netanyahu says Iran no longer has uranium enrichment capacity Iran war-induced fertilizer...
SelectQuote ( SLQT ) on Wednesday said it received a notice from the New York Stock Exchange for failing to meet continued listing standards after its average share price fell below $1 over 30 consecutive trading days. The company said it intends to regain compliance within the six-month cure period by lifting its share price above the required threshold. SelectQuote added its stock will continue ...
SelectQuote ( SLQT ) on Wednesday said it received a notice from the New York Stock Exchange for failing to meet continued listing standards after its average share price fell below $1 over 30 consecutive trading days. The company said it intends to regain compliance within the six-month cure period by lifting its share price above the required threshold. SelectQuote added its stock will continue to trade on the NYSE during the cure period, subject to compliance with other listing standards. Source: Press Release More on SelectQuote SelectQuote, Inc. 2026 Q2 - Results - Earnings Call Presentation SelectQuote, Inc. (SLQT) Q2 2026 Earnings Call Transcript SelectQuote Q2 Earnings Preview: Sell The Medicare Reimbursement News (Rating Downgrade) SelectQuote lowers 2026 guidance amid $40M headwind but targets 20%+ Senior EBITDA margin and $25–35M operating cash flow SelectQuote Q2 2026 Earnings Preview
NASA's announcement Tuesday that it will "pause" work on a lunar space station and focus on building a surface base on the Moon was no big surprise to anyone paying attention to the Trump administration's space policy. But what should NASA do with hardware already built for the Gateway outpost? NASA spent close to $4.5 billion on developing a human-tended complex in orbit around the Moon since the...
NASA's announcement Tuesday that it will "pause" work on a lunar space station and focus on building a surface base on the Moon was no big surprise to anyone paying attention to the Trump administration's space policy. But what should NASA do with hardware already built for the Gateway outpost? NASA spent close to $4.5 billion on developing a human-tended complex in orbit around the Moon since the Gateway program's official start in 2019. There are pieces of the station undergoing construction and testing in factories scattered around the world. The centerpiece of Gateway, called the Power and Propulsion Element, is closest to being ready for launch. NASA's rejigged exploration roadmap, revealed Tuesday in an all-day event at NASA headquarters in Washington, calls for repurposing the core module for a nuclear-electric propulsion demonstration in deep space. Read full article Comments
Shares of application security provider F5 (NASDAQ:FFIV) jumped 2.8% in the afternoon session after the company announced two significant collaborations aimed at strengthening its position in the artificial intelligence (AI) market.
Shares of application security provider F5 (NASDAQ:FFIV) jumped 2.8% in the afternoon session after the company announced two significant collaborations aimed at strengthening its position in the artificial intelligence (AI) market.
Emergent BioSolutions ( EBS ) announced on Wednesday it has secured a contract award valued at approximately $54M to deliver CNJ-016® to the Administration for Strategic Preparedness and Response ( ASPR ), part of the U. S. Department of Health and Human Services ( HHS ), for smallpox preparedness. In addition, Emergent has secured new incremental orders with an international government partner va...
Emergent BioSolutions ( EBS ) announced on Wednesday it has secured a contract award valued at approximately $54M to deliver CNJ-016® to the Administration for Strategic Preparedness and Response ( ASPR ), part of the U. S. Department of Health and Human Services ( HHS ), for smallpox preparedness. In addition, Emergent has secured new incremental orders with an international government partner valued at $6.6M. This represents product orders for ACAM2000® (Smallpox (Vaccinia) Vaccine, Live) within Emergent’s medical countermeasures portfolio and will support the partner’s smallpox biodefense strategy. The announcement follows Emergent’s recent execution of multi-year agreements with the Government of Canada valued at up to C$140M to support the country’s biologic threat preparedness and response infrastructure, of which more than C$35M in orders will be received in 2026. Source: Press Release More on Emergent Biosolutions Emergent BioSolutions Earnings: Revenue, Margins, And GAAP Losses Paint A Mixed Picture Emergent BioSolutions plummets on weak 2026 revenue guidance, Q4 results Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances
Artificial Intelligence, Real Misallocation Authored by Peter C. Earle, Ph.D, Artificial intelligence may well be the most important technological development of the coming decade-and that is exactly why the current capital surge around it warrants skepticism . History is littered with transformative innovations that were nonetheless disastrously overbuilt and mispriced in their early phases. Aust...
Artificial Intelligence, Real Misallocation Authored by Peter C. Earle, Ph.D, Artificial intelligence may well be the most important technological development of the coming decade-and that is exactly why the current capital surge around it warrants skepticism . History is littered with transformative innovations that were nonetheless disastrously overbuilt and mispriced in their early phases. Austrian Business Cycle Theory was never a children’s story in which every boom ends with clowns, ashes, and worthless machinery; its real claim is subtler and nastier. When the price of time is falsified-when interest rates are pushed below their natural rate-often proxied, however imperfectly, by modern estimates of the neutral rate-entrepreneurs are encouraged to undertake projects that are more roundabout, more capital-intensive, and more time-sensitive than underlying saving and final demand can actually support. The neutral rate is a policy construct; the natural rate is an economic reality. Some of those projects may still embody genuine innovation. The problem is not that AI must be fake; it is that a very real technological advance can be financed, priced, and physically built in ways that are wildly uneconomic. That distinction matters because AI is about as roundabout as modern capitalism gets. This is not a boom in apps and slogans alone; it is a boom in data centers, power, cooling, transformers, specialized semiconductors, fiber, land, and the commodities and construction needed to house and feed all of it . Reuters reports that Alphabet, Amazon, Meta, and Microsoft are expected to spend more than $630 billion combined on AI-related infrastructure in 2026, up sharply from 2025, while separate Reuters reporting says Amazon alone projects roughly $200 billion of 2026 capex. Analysts also expect the hyperscalers’ debt issuance to keep climbing, with BofA lifting its 2026 forecast to $175 billion after Amazon’s jumbo deal and Reuters noting that these firms issued $12...
Orezone Gold press release ( ORZCF ): Q4 Non-GAAP EPS of $0.05. Revenue of $130.5M (+42.1% Y/Y) misses by $60.01M . Adjusted EBITDA of $63.0M, Adjusted Earnings attributable to Orezone shareholders of $27.3M, and Adjusted Earnings per Share attributable to Orezone shareholders of $0.05. Cash flow from operations before changes in working capital of $57.0M and after changes in working capital of $5...
Orezone Gold press release ( ORZCF ): Q4 Non-GAAP EPS of $0.05. Revenue of $130.5M (+42.1% Y/Y) misses by $60.01M . Adjusted EBITDA of $63.0M, Adjusted Earnings attributable to Orezone shareholders of $27.3M, and Adjusted Earnings per Share attributable to Orezone shareholders of $0.05. Cash flow from operations before changes in working capital of $57.0M and after changes in working capital of $52.6M. Cash on hand of $98.0M and bullion inventory of 3,175 oz with a market value of $13.9M at December 31, 2025. More on Orezone Gold Historical earnings data for Orezone Gold Financial information for Orezone Gold
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. (Source: Bloomberg)
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. (Source: Bloomberg)
Karman Holdings press release ( KRMN ): Q4 Non-GAAP EPS of $0.11 in-line. Revenue of $134.5M (+47.4% Y/Y) beats by $1.96M . For the full fiscal year 2026, the Company increases its expectations for total revenue to between $715M and $730M vs consensus of $710.54M and for non-GAAP Adjusted EBITDA to between $207 million and $218 million, excluding any future acquisitions. More on Karman Holdings Ka...
Karman Holdings press release ( KRMN ): Q4 Non-GAAP EPS of $0.11 in-line. Revenue of $134.5M (+47.4% Y/Y) beats by $1.96M . For the full fiscal year 2026, the Company increases its expectations for total revenue to between $715M and $730M vs consensus of $710.54M and for non-GAAP Adjusted EBITDA to between $207 million and $218 million, excluding any future acquisitions. More on Karman Holdings Karman Holdings Inc. (KRMN) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript Karman Holdings Set To Deliver Market-Leading Growth Across Land, Sea, Air, And Space Karman Holdings Inc. (KRMN) Presents at 47th Annual TD Cowen Aerospace and Defense Conference Transcript Karman Holdings Q4 2025 Earnings Preview Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag
Starbucks ( SBUX ) is testing new ordering channels in licensed stores to speed service at busy locations, especially where traffic is high and efficiency matters most. The chain is looking at ways to utilize ordering kiosks and scheduled orders through the app as part of the process. The Seattle-based company's move is part of a broader effort to make ordering smoother and reduce bottlenecks in s...
Starbucks ( SBUX ) is testing new ordering channels in licensed stores to speed service at busy locations, especially where traffic is high and efficiency matters most. The chain is looking at ways to utilize ordering kiosks and scheduled orders through the app as part of the process. The Seattle-based company's move is part of a broader effort to make ordering smoother and reduce bottlenecks in stores that serve customers through multiple channels. "Whether someone is grabbing coffee on their commute, at the airport, inside a hospital, at a hotel, or on a business or university campus, they expect the same unmistakable Starbucks experience—the same quality, care, and handoff. Our responsibility is to deliver that experience seamlessly, wherever Starbucks shows up and however customers choose to order," wrote Starbucks ( SBUX ) Senior VP Aaron Koransky in a recent blog post. One of the primary goals is for Starbucks ( SBUX ) customers to experience greater consistency at the Starbucks they already visit. As part of its strategy reset, Starbucks ( SBUX ) is also testing order-ahead scheduling, refining order sequencing, and using AI tools to make mobile and in-store orders flow better. The company is also reportedly leaning into a "test-and-scale" approach and new store formats as part of its turnaround plan. Other major initiatives by Starbucks (SBYX) include trimming some mobile-only locations, investing in staffing and store upgrades, and planning new coffeehouse designs to restore more in-store traffic and support long-term growth. More on Starbucks Starbucks: Improving, But Where Are The Bucks? Starbucks Is Getting Its Glow-Up, But Risks Remain Starbucks: What The 3-Step DuPont Model Reveals About Valuation Starbucks is cut at RBC with the risk-reward profile seen as balanced Proxy firms warn Starbucks of reputational risk from persistent labor issues
In the video above, Yahoo Finance Senior Reporter Ines Ferre takes a look at what Wall Street and Polymarket are saying about the odds of a US recession this year, while Laffer Tengler Investments CEO and CIO Nancy Tengler shares her thoughts on the growing value of artificial intelligence (AI)–fueled productivity gains.
In the video above, Yahoo Finance Senior Reporter Ines Ferre takes a look at what Wall Street and Polymarket are saying about the odds of a US recession this year, while Laffer Tengler Investments CEO and CIO Nancy Tengler shares her thoughts on the growing value of artificial intelligence (AI)–fueled productivity gains.